• 1
    Nishimura, F., Dusak, J. E., Eguchi, J., Zhu, X., Gambotto, A., Storkus, W. J. and Okada, H., Adoptive transfer of type 1 CTL mediates effective anti-central nervous system tumor response: critical roles of IFN-inducible protein-10. Cancer Res. 2006. 66: 44784487.
  • 2
    Sasaki, K., Zhu, X., Vasquez, C., Nishimura, F., Dusak, J. E., Huang, J., Fujita, M. et al., Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors. Cancer Res. 2007. 67: 64516458.
  • 3
    Biedermann, T., Mailhammer, R., Mai, A., Sander, C., Ogilvie, A., Brombacher, F., Maier, K. et al., Reversal of established delayed type hypersensitivity reactions following therapy with IL-4 or antigen-specific Th2 cells. Eur. J. Immunol. 2001. 31:15821591.
  • 4
    Sasaki, K., Tsuji, T., Jinushi, T., Matsuzaki, J., Sato, T., Chamoto, K., Togashi, Y. et al., Differential regulation of VLA-2 expression on Th1 and Th2 cells: a novel marker for the classification of Th subsets. Int. Immunol. 2003. 15: 701710.
  • 5
    Wakim, L. M., Waithman, J., van Rooijen, N., Heath, W. R. and Carbone, F. R., Dendritic cell-induced memory T cell activation in non lymphoid tissues. Science 2008. 319: 198202.
  • 6
    O'Garra, A. and Arai, N., The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends. Cell Biol. 2000. 10: 542550.
  • 7
    Mosmann, T. R. and Coffman, R. L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989. 7: 145173.
  • 8
    Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T. R., Howard, M., Moore, K. W. and O'Garra, A., IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 1991. 146: 34443451.
  • 9
    Sad, S. and Mosmann, T. R., Interleukin (IL) 4, in the absence of antigen stimulation, induces an anergy-like state in differentiated CD8+ TC1 cells: loss of IL-2 synthesis and autonomous proliferation but retention of cytotoxicity and synthesis of other cytokines. J. Exp. Med. 1995. 182: 15051515.
  • 10
    Sad, S., Li, L. and Mosmann, T. R., Cytokine-deficient CD8+ Tc1 cells induced by IL-4: retained inflammation and perforin and Fas cytotoxicity but compromised long term killing of tumor cells. J. Immunol. 1997. 159: 606613.
  • 11
    Del Vecchio, M., Bajetta, E., Canova, S., Lotze, M., Wesa, A., Parmiani, G. and Anichini, A., Interleukin-12: biological properties and clinical application. Clin. Cancer Res. 2007. 13: 46774685.
  • 12
    Gajewski, T. F. and Fitch, F. W., Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. J. Immunol. 1988. 140: 42454252.
  • 13
    Fiorentino, D. F., Bond, M. W. and Mosmann, T. R., Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989. 170: 20812095.
  • 14
    Mueller, R., Krahl, T. and Sarvetnick, N., Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 1996. 184: 10931099.
  • 15
    Koch, F., Stanzl, U., Jennewein, P., Janke, K., Heufler, C., Kampgen, E., Romani, N. and Schuler, G., High level IL-12 production by murine dendritic cells: up-regulation via MHC class II and CD40 molecules and down-regulation by IL-4 and IL-10. J. Exp. Med. 1996. 184: 741746.
  • 16
    Lobb, R. R. and Hemler, M. E., The pathophysiologic role of alpha 4 integrins in vivo. J. Clin. Invest. 1994. 94: 17221728.
  • 17
    Pribila, J. T., Quale, A. C., Mueller, K. L. and Shimizu, Y., Integrins and T cell-mediated immunity. Annu. Rev. Immunol. 2004. 22: 157180.
  • 18
    Hochrein, H., O'Keeffe, M., Luft, T., Vandenabeele, S., Grumont, R. J., Maraskovsky, E., and Shortman, K., Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells. J. Exp. Med. 2000. 192: 823833.
  • 19
    Baron, J. L., Madri, J. A., Ruddle, N. H., Hashim, G. and Janeway Jr C. A., Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 1993. 177: 5768.
  • 20
    Egwuagu, C. E., Yu, C. R., Zhang, M., Mahdi, R. M., Kim, S. J. and Gery, I., Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance. J. Immunol. 2002. 168: 31813187.
  • 21
    Prokopchuk, O., Liu, Y., Henne-Bruns, D. and Kornmann, M., Interleukin-4 enhances proliferation of human pancreatic cancer cells: evidence for autocrine and paracrine actions. Br. J. Cancer 2005. 92: 921928.
  • 22
    Tatsumi, T., Herrem, C. J., Olson, W. C., Finke, J. H., Bukowski, R. M., Kinch, M., Ranieri, E. and Storkus, W. J., Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma. Cancer Res. 2003. 63: 44814489.
  • 23
    Ogawa, M., Tsutsui, T., Zou, J. P., Mu, J., Wijesuriya, R., Yu, W. G., Herrmann, S. et al., Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin 12. Cancer Res. 1997. 57: 22162222.
  • 24
    Strieter, R. M., Burdick, M. D., Mestas, J., Gomperts, B., Keane, M. P. and Belperio, J. A., Cancer CXC chemokine networks and tumour angiogenesis. Eur. J. Cancer. 2006. 42: 768778.
  • 25
    Bukowski, R. M., Rayman, P., Molto, L., Tannenbaum, C. S., Olencki, T., Peereboom, D., Tubbs, R. et al., Interferon-γ and CXC chemokine induction by interleukin 12 in renal cell carcinoma. Clin. Cancer Res. 1999. 5: 27802789.
  • 26
    Gajewski, T. F., Joyce, J. and Fitch, F. W., Antiproliferative effect of IFN-γ in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-γ. J. Immunol. 1989. 143: 1522.